propan-2-yl 4-(6-chloro-5-methylpyrimidin-4-yl)oxypiperidine-1-carboxylate

Cc1nc(S(C)(=O)=O)ccc1Nc1ncnc(OC2CCN(C(=O)OC(C)C)CC2)c1C
Reaction #212
収率 54.1%750 AstraZeneca ELN dataset
Cc1c(Oc2ccc(F)cc2F)ncnc1OC1CCN(C(=O)OC(C)C)CC1
Reaction #234737
DOI: 10.1039/C8SC04228DTraining data from https://doi.org/10.1039/C8SC04228D (9/10)
Cc1c(Nc2cc(F)c(Br)cc2F)ncnc1OC1CCN(C(=O)OC(C)C)CC1
Reaction #267352
DOI: 10.1039/C8SC04228DTraining data from https://doi.org/10.1039/C8SC04228D (6/10)
Cc1c(Cl)ncnc1OC1CCN(C(=O)OC(C)C)CC1
Reaction #535755
9b
DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-2013_07
Cc1c(Cl)ncnc1OC1CCN(C(=O)OC(C)C)CC1
Reaction #777164
DOI: 10.1039/C8SC04228DTraining data from https://doi.org/10.1039/C8SC04228D (3/10)
Cc1c(Oc2ccc(CC(=O)O)cc2F)ncnc1OC1CCN(C(=O)OC(C)C)CC1
Reaction #778413
DOI: 10.1039/C8SC04228DTraining data from https://doi.org/10.1039/C8SC04228D (3/10)
Cc1cc(Cl)ncc1Nc1ncnc(OC2CCN(C(=O)OC(C)C)CC2)c1C
Reaction #886993
DOI: 10.1039/C8SC04228DTest data from https://doi.org/10.1039/C8SC04228D
Cc1c(Oc2ccc(CCN3CCOCC3)cc2F)ncnc1OC1CCN(C(=O)OC(C)C)CC1
Reaction #907518
DOI: 10.1039/C8SC04228DTest data from https://doi.org/10.1039/C8SC04228D
Cc1c(Oc2ccc(S(C)(=O)=O)cc2F)ncnc1OC1CCN(C(=O)OC(C)C)CC1
Reaction #923136
DOI: 10.1039/C8SC04228DTest data from https://doi.org/10.1039/C8SC04228D
Cc1c(Cl)ncnc1OC1CCN(C(=O)OC(C)C)CC1
Reaction #1029418
DOI: 10.1039/C8SC04228DValidation data from https://doi.org/10.1039/C8SC04228D
Cc1c(Cl)ncnc1OC1CCN(C(=O)OC(C)C)CC1
Reaction #1048452
DOI: 10.1039/C8SC04228DValidation data from https://doi.org/10.1039/C8SC04228D
Cc1c(Cl)ncnc1OC1CCN(C(=O)OC(C)C)CC1
Reaction #1123954
4-(6-chloro-5-methyl-pyrimidin-4-yloxy)-piperidine-1-carboxylic acid isopropyl ester
収率 98.3%DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-2013_10
Cc1c(Nc2ccc(I)cc2F)ncnc1OC1CCN(C(=O)OC(C)C)CC1
Reaction #1123955
solid
収率 47.1%DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-2013_10
Cc1c(Nc2cc(F)c(Br)cc2F)ncnc1OC1CCN(C(=O)OC(C)C)CC1
Reaction #1123956
solid
収率 41.0%DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-2013_10
Cc1nc(Cl)ccc1Nc1ncnc(OC2CCN(C(=O)OC(C)C)CC2)c1C
Reaction #1123957
solid
収率 31.0%DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-2013_10
Cc1cc(Cl)ncc1Nc1ncnc(OC2CCN(C(=O)OC(C)C)CC2)c1C
Reaction #1123961
solid
収率 29.1%DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-2013_10
Cc1c(Nc2ccc(S(=O)(=O)NCCOC(C)C)cc2F)ncnc1OC1CCN(C(=O)OC(C)C)CC1
Reaction #1123964
solid
収率 30.1%DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-2013_10
Cc1nc(Cl)ccc1Oc1ncnc(OC2CCN(C(=O)OC(C)C)CC2)c1C
Reaction #1123988
solid
収率 71.0%DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-2013_10
Cc1c(Oc2ccc(F)cc2F)ncnc1OC1CCN(C(=O)OC(C)C)CC1
Reaction #1123989
solid
収率 69.0%DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-2013_10
Cc1c(Oc2ccc(CCN3CCOCC3)cc2F)ncnc1OC1CCN(C(=O)OC(C)C)CC1
Reaction #1123996
4-{6-[2-Fluoro-4-(2-morpholin-4-yl-ethyl)-phenoxy]-5-methyl-pyrimidin-4-yloxy}-piperidine-1-carboxylic acid isopropyl ester
DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-2013_10
1 ページ次のページ